Drug Trial Radar · NCT01368536
Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes
Last checked: Nov 19, 2026Latest source record: Mar 21, 2013 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Terminated
Enrollment
975
Actual
Start
May 2011
Primary completion
Feb 2012
Study completion Feb 2012
Sponsor
- Lead sponsor
- Novartis PharmaceuticalsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Jun 8, 2011
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This was a study to assess the safety and efficacy of Valturna and amlodipine or Valturna and chlorthalidone when compared to Valturna alone in patients with stage 2 hypertension and diabetes mellitus 2.
Conditions
- Hypertension
- Stage 2 Hypertension
- Diabetes
Interventions
ValturnaDrug
Valturna (aliskiren 150 mg/valsartan 160 mg) tablet
AmlodipineDrug
Amlodipine 5 mg and 10 mg capsule
ChlorthalidoneDrug
Chlorthalidone 15 mg and 25 mg capsule
Placebo of Valturna TabletDrug
Matching placebo of valturna tablet
Placebo CapsuleDrug
Matching placebo of Amlodipine capsule OR Matching placebo of chlorthalidone capsule
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline in Mean Sitting Systolic Blood Pressure (MSSBP) After 12 Weeks of Treatment Ending With the Combination of Valturna and Amlodipine Versus Valturna AloneTime frame: Baseline, 12 weeks
Locations
97 sites in 2 countries. Site status is shown where the registry gives one.
Novartis Investigative Site
Athens, Alabama
Novartis Investigative Site
Florence, Alabama
Novartis Investigative Site
Huntsville, Alabama
Novartis Investigative Site
Montgomery, Alabama
Novartis Investigative Site
Muscle Shoals, Alabama
Novartis Investigative Site
Chandler, Arizona
Novartis Investigative Site
Little Rock, Arkansas
Novartis Investigative Site
Buena Park, California
Novartis Investigative Site
Fair Oaks, California
Novartis Investigative Site
Fresno, California
Novartis Investigative Site
Healdsburg, California
Novartis Investigative Site
Los Angeles, California
Novartis Investigative Site
Orangevale, California
Novartis Investigative Site
Riverside, California
Novartis Investigative Site
Roseville, California
Novartis Investigative Site
Sacramento, California
Novartis Investigative Site
Santa Ana, California
Novartis Investigative Site
West Covina, California
Novartis Investigative Site
Shelton, Connecticut
Novartis Investigative Site
Fort Lauderdale, Florida
Novartis Investigative Site
Fort Lauderdale, Florida
Novartis Investigative Site
Jupiter, Florida
Novartis Investigative Site
Lauderdale Lakes, Florida
Novartis Investigative Site
North Miami Beach, Florida
Novartis Investigative Site
St. Petersburg, Florida
Novartis Investigative Site
Tampa, Florida
Novartis Investigative Site
West Palm Beach, Florida
Novartis Investigative Site
Augusta, Georgia
Novartis Investigative Site
Honolulu, Hawaii
Novartis Investigative Site
Chicago, Illinois
Novartis Investigative Site
Chicago, Illinois
Novartis Investigative Site
Chicago, Illinois
Novartis Investigative Site
Gurnee, Illinois
Novartis Investigative Site
Lansing, Kansas
Novartis Investigative Site
Topeka, Kansas
Novartis Investigative Site
Beltsville, Maine
Novartis Investigative Site
Waltham, Massachusetts
Novartis Investigative Site
Wellesley Hills, Massachusetts
Novartis Investigative Site
Brooklyn Center, Minnesota
Novartis Investigative Site
Belzoni, Mississippi
Showing 40 of 97 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.